Abstract: Systems and methods presented herein include a venue system that includes a guest recognition system configured to recognize one or more guests in a venue, and a guest experience analysis system configured to receive data relating to the recognized one or more guests from the guest recognition system, to generate guest experience information relating to the recognized one or more guests based at least in part on the received data relating to the recognized one or more guests, and to transmit the guest experience information relating to the recognized one or more guests to an augmented reality display device for display on an augmented reality display of the augmented reality display device.

Abstract: A bone conduction hearing-aid unit that is entirely embedded under a scalp. The bone conduction hearing-aid unit includes a vibration generating device configured to generate vibration, and an anchor fixed to a skull and configured to transmit the vibration to the skull. The vibration generating device is detachably fixed to the anchor.

Abstract: Disclosed are methods and compositions related to methods of treating, ameliorating, mitigating, slowing, arresting, preventing or reversing various diseases and conditions, including age-related obesity, age-related increases in blood lipid levels, age-related decreases in insulin sensitivity, age-related decreases in memory function, and age-related changes in eye function such as macular degeneration. The methods comprise administering nicotinamide mononucleotide (NMN) to a subject. In some embodiments, the administration can be oral administration. Also disclosed are pharmaceutical compositions comprising NMN.

Abstract: A nanocomposite comprising a nanocarrier, a pharmaceutical compound disposed on a surface of the nanocarrier, and a biocompatible coating disposed on the pharmaceutical compound. The nanocarrier comprises nanotubes of a silicate or aluminosilicate material, preferably halloysite, and nanoparticles of a magnetic transition metal ferrite material of formula MFe2O4, where M is selected from the group consisting of zinc, nickel, copper, manganese, and cobalt, the nanoparticles being disposed on an interior and/or an exterior surface of the nanotubes. The pharmaceutical compound is disposed in the pores and/or on the surface of the nanocarrier by a solution phase impregnation process. The nanomedicinal 10 composition is used in a method of treating pulmonary infections. The nanomedicinal composition may be administered by inhalation.

Abstract: A bore embolization catheter comprising a catheter main body extending from a catheter junction to a distal end and housing a first lumen, a second lumen, and a third lumen; a detachment zone on the catheter main body configured to allow the catheter main body to be broken; an agent delivery hole on the catheter main body between the detachment zone and the distal end; an end port at the distal end; an inflatable balloon on the catheter main body between the agent delivery hole and the distal end; and a first port in communication with the inflatable balloon through the first lumen, a second port in communication with the agent delivery hole through the second lumen, and a third port in communication with the end port through the third lumen.

Abstract: A bone tissue regeneration product, a method for preparing the bone tissue regeneration product and, and a method for repairing a bone defect. The new use of IGSF10 of the present disclosure can reduce the effective concentration of BMP without obvious adverse reactions, thereby exploring a method to promote bone tissue regeneration and providing new ideas for the treatment of bone defects. The present disclosure is capable of promoting non-bone related cells to produce bones; the method of the present disclosure is also capable of inhibiting the bone loss in inflammatory environments.

Abstract: The present invention provides pyrazole pyrimidine derivatives which inhibit Casein kinase I (CKI) and/or Interleukin-1 receptor-associated kinase 1 (IRAK1) and methods of their manufacture, compositions comprising them and uses thereof in methods of treating malignant disease and disorders and methods for treating inflammatory diseases and disorders.

Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.

Abstract: A battery housing may include a primary vent channel, auxiliary vent channels, and receptacles for receiving cells. Each receptacle may have sidewalls that operate as barriers to cell venting events occurring in other receptacles, an auxiliary vent channel opening to a respective auxiliary vent channel, and a primary vent channel opening to the primary vent channel. Each primary vent channel opening may be aligned with a position of a vent valve of a cell disposed within a respective receptacle such that internal substances expelled from the vent valve or a rupture at the vent valve in an associated vent direction are directed into the primary vent channel. Each auxiliary vent channel opening is not aligned with a respective primary vent channel opening and a respective position of a vent valve.

Abstract: A method and reactor for a hybrid thermo-electrochemical cycle using a layered reactive element is disclosed. The method includes heating the reactive element with a heat source, the reactive element having a metal oxide core that is redox-active, an outer layer, and an ion conductor layer between the core and the outer layer. The method includes increasing a chemical potential of oxygen in the core, driving O2? ions out as O2, the chemical potential increased through applying a first bias voltage between the core and the outer layer. The method includes exposing the reactive element to an input gas, and decreasing the chemical potential of oxygen in the core, driving oxygen from the input gas into the core leaving a gas product, the chemical potential decreased through applying a second bias voltage between the core and the outer layer. The first and second bias voltages have opposite polarity.

Abstract: The present invention relates to a millimeter-wave beam tracking method in a microwave and millimeter wave heterogeneous network scenario, including: establishing a millimeter-wave beam tracking problem in the microwave and millimeter wave heterogeneous network scenario; for the millimeter-wave beam tracking problem, constructing a deep neural network (DNN) fusion model that performs millimeter-wave beam tracking by using time sequence microwave channel information and user location information; pre-training the DNN fusion model by using training data; configuring a pre-trained beam tracking deep learning model in a base station controller of an actual access network, performing millimeter-wave beam tracking according to actually input microwave channel information and user location information, and selecting a millimeter-wave optimum beam; and collecting the input information to continuously train and update the DNN fusion model.

Abstract: A memory system and an electronic system including the same are provided. The memory system includes a memory device configured to receive data, and a hot page logic configured to receive an address for the data, determine that the address is for a hot page based on an input frequency and an input order of the address, and create hot page information including the address that was determined as associated with the hot page such that a page migration operation of the data is performed.

Abstract: Modified zeolites may include a microporous framework including a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework may include at least silicon atoms and oxygen atoms. The modified zeolite may include a plurality of mesopores having diameters of greater than 2 nm and less than or equal to 50 nm, wherein the plurality of mesopores are ordered with cubic symmetry. The modified zeolite may include a plurality of titanium atoms each bonded to four bridging oxygen atoms, wherein each of the bridging oxygen atoms bonded to the titanium atoms bridges one of the plurality of the titanium atoms and a silicon atom of the microporous framework.

Abstract: In one aspect, described is a method of selecting or identifying an agent that inhibits a target protein having an active site. In another aspect, described is a method of selecting an agent that inhibits a target protein having an active site for further optimization. In some embodiments, the methods include measuring or predicting stability of an induced fit conformation of an agent contacted to an active site of the protein, wherein the agent is selected if the stability of the induced fit conformation of the agent contacted to the active site of the protein is increased relative to a reference stability.

Abstract: Time multiplexing an electromagnetic trap beam may be used to generate trap shapes/geometries to trap one or more particles with one electromagnetic beam by directing the electromagnetic beam at a pattern of different locations with sufficient rapidity to form an effective shape/geometry. Additionally, multiplexing an electromagnetic trap beam may be used to shutter trapping electromagnetic radiation to protect a viewer, use the same beam for multiple functions, move and organize particles, and generate illumination effects.

Abstract: A method includes forming a first pull-up transistor and a first pass-gate transistor over a substrate at a first level height, the first pull-up and first pass-gate transistors being of a dual port static random access memory (SRAM) cell; forming a first pull-down transistor and a second pass-gate transistor of the dual port SRAM cell over the substrate at a second level height; forming a second pull-down transistor and a third pass-gate transistor of the dual port SRAM cell over the substrate at a third level height; forming a second pull-up transistor and a fourth pass-gate transistor of the dual port SRAM cell over the substrate at a fourth level height.

Abstract: The present invention relates to rhomboidal phase bismuth oxide that maintains electric conductivity of at least about 1×10?2 S/cm at temperature of about 500° C. for at least about 100 hours. In particular, the bismuth oxides of the invention have stable conductivity at a temperature range from about 500° C. to about 550° C.

Abstract: The present disclosure relates to the technical field of optimization of charging facilities, and in particular, to a day-ahead coordinated optimization scheduling method for a truck mobile charging station.

Abstract: A displacement-sensing Doppler radar with ultra-low noise and high sensing resolution is provided. The radar includes N two frequency synthesizers to respectively generate, at different frequencies, a transmitted signal that is radiated toward a target object, and a local oscillator (LO) signal. The radar further includes a mixer and a rectifier to: (1) receive a returned signal from the target object carrying phase delays corresponding to detected displacements of the target object; (2) mix the returned signal and the LO signal to generate a down-converted sine-wave intermediate frequency (IF) signal; and (3) rectify the sine-wave IF signal to a square-wave IF signal, which also carries the displacement-induced phase delays. The radar also includes a phase demodulation module to convert the displacement-induced phase delays into a pulse-modulated signal. The radar further includes a low-pass filter to convert the modulated pulse signal into an output voltage signal indicative of the detected displacements.

Abstract: The present invention relates to a composition for preventing or treating Alzheimer's disease, comprising a phospholipase C (PLC) activator as an active ingredient. A composition comprising the PLC activator of the present invention as an active ingredient restores the S-eCB mobilization suppressed by A?O, recovers the synaptic plasticity impaired by A?O, and not only recovers PLC?1 protein levels to normal levels in A?O-treated mouse hippocampal slices and 5XFAD mouse hippocampal slices in the chronic stage of AD, but also recovers contextual fear memory impairment in AD mice, and thus is expected to be usefully used for preventing or treating Alzheimer's disease.